BS EN ISO 23500-1:2019
$215.11
Preparation and quality management of fluids for haemodialysis and related therapies – General requirements
Published By | Publication Date | Number of Pages |
BSI | 2019 | 96 |
1.1 General
This document is the base standard for a number of other standards dealing with water treatment equipment, water, dialysis water, concentrates, and dialysis fluid (ISO 23500 series) and provides dialysis practitioners with guidance on the preparation of dialysis fluid for haemodialysis and related therapies and substitution fluid for use in online therapies, such as haemodiafiltration and haemofiltration. As such, this document functions as a recommended practice.
This document does not address clinical issues that might be associated with inappropriate usage of the water, dialysis water, concentrates, or dialysis fluid. Healthcare professionals involved in the provision of treatment for kidney failure should make the final decision regarding the applications with which these fluids are used, for example, haemodialysis, haemodiafiltration, high-flux haemodialysis, and the reprocessing of dialysers, and need to be aware of the issues that the use of inappropriate fluid quality raises in each of the therapies.
The concepts incorporated in this document should not be considered inflexible or static. The recommendations presented here should be reviewed periodically in order to assimilate increased understanding of the role of dialysis fluid purity in patient outcomes and technological developments.
1.2 Inclusions
This document addresses the user’s responsibility for dialysis fluid once the equipment used in its preparation has been delivered and installed.
For the purposes of this document, dialysis fluid includes:
-
dialysis water (see 3.17 for definition) used for the preparation of dialysis fluid and substitution fluid,
-
dialysis water used for the preparation of concentrates at the user’s facility,
-
concentrates,
-
the final dialysis fluid and substitution fluid.
The scope of this document includes
-
the quality management of equipment used to treat and distribute water used for the preparation of dialysis fluid and substitution fluid, from the point at which municipal water enters the dialysis facility to the point at which the final dialysis fluid enters the dialyser or the point at which substitution fluid is infused,
-
equipment used to prepare concentrate from powder or other highly concentrated media at a dialysis facility, and
-
preparation of the final dialysis fluid or substitution fluid from dialysis water and concentrates.
NOTE Because water used to prepare dialysis fluid can also be used to reprocess dialysers not marked intended for single use, this aspect of water use is also covered by this document.
1.3 Exclusions
This document does not apply to sorbent-based dialysis fluid regeneration systems that regenerate and recirculate small volumes of dialysis fluid, systems for continuous renal replacement therapy that use pre-packaged solutions, and systems and solutions for peritoneal dialysis.
PDF Catalog
PDF Pages | PDF Title |
---|---|
2 | National foreword |
4 | European foreword |
7 | Foreword |
8 | Introduction |
9 | 1 Scope 1.1 General 1.2 Inclusions |
10 | 1.3 Exclusions 2 Normative references 3 Terms and definitions |
17 | 4 Quality requirements 4.1 General 4.2 Dialysis water 4.2.1 General 4.2.2 Chemical contaminants in dialysis water |
19 | 4.2.3 Organic Carbon, pesticides and other chemicals 4.2.4 Microbiological contaminants in dialysis water |
20 | 4.3 Requirements for concentrate 4.3.1 Chemical and microbiological contaminants in concentrate 4.3.2 Water used to prepare concentrate 4.4 Requirements for dialysis fluid 4.4.1 General |
21 | 4.4.2 Microbiological requirements for standard dialysis fluid 4.4.3 Microbiological requirements for ultrapure dialysis fluid 4.4.4 Microbiological requirements for online-prepared substitution fluid 4.5 Record retention |
22 | 5 Critical aspects of system design 5.1 General 5.2 Technical aspects |
23 | 5.3 Microbiological aspects |
24 | 5.4 Environmental impact 6 Validation of system performance 6.1 General |
25 | 6.2 Validation plan 6.3 Installation and operational qualification |
26 | 6.4 Performance qualification 6.5 Routine surveillance and revalidation |
27 | 7 Quality management 7.1 General 7.2 Surveillance of fluid quality 7.2.1 Surveillance of dialysis water quality |
28 | 7.2.2 Surveillance of concentrate quality 7.2.3 Surveillance of dialysis fluid quality 7.3 Surveillance of water treatment equipment 7.3.1 General 7.3.2 Surveillance of sediment filters |
29 | 7.3.3 Surveillance of cartridge filters 7.3.4 Surveillance of softeners 7.3.5 Surveillance of carbon media |
30 | 7.3.6 Surveillance of chemical injection systems 7.3.7 Surveillance of reverse osmosis |
32 | 7.3.8 Surveillance of deionization 7.3.9 Surveillance of endotoxin-retentive filters 7.4 Surveillance of dialysis water storage and distribution 7.4.1 Surveillance of water storage tanks 7.4.2 Surveillance of the water distribution systems |
33 | 7.4.3 Surveillance of bacterial control devices 7.5 Surveillance of concentrate preparation 7.5.1 Surveillance of mixing systems |
34 | 7.5.2 Surveillance of additives 7.6 Surveillance of concentrate distribution 7.7 Surveillance of dialysis fluid proportioning 8 Strategies for microbiological control 8.1 General |
35 | 8.2 Disinfection 8.2.1 General 8.2.2 Microbiological aspects of fluid system design |
36 | 8.2.3 Disinfection frequency |
37 | 8.3 Microbiological surveillance methods 8.3.1 General 8.3.2 Sample collection |
38 | 8.3.3 Heterotrophic plate count |
40 | 8.3.4 Bacterial endotoxin test 8.3.5 Determination of yeast and mould 9 Location of and access to the water treatment system 10 Personnel |
41 | Annex A (informative) Rationale for the development and provisions of this document |
46 | Annex B (informative) Equipment |
64 | Annex C (informative) Surveillance guidelines for water treatment equipment, distribution systems, and dialysis fluid |
69 | Annex D (informative) Strategies for microbiological control |
76 | Annex E (informative) Validation |
79 | Annex F (informative) Special considerations for home haemodialysis |
85 | Annex G (informative) Special considerations for acute haemodialysis |
90 | Bibliography |